Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol plus tourniquet versus tourniquet alone for blood loss reduction during abdominal myomectomy in Kano
PACTR202412492883248Not yet recruiting
- Sponsor
- Amina Zangina Maje
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Fibromyoma (LM) comparing Misoprostol group with Placebo group (2 arms). Primary endpoint: intraoperative blood loss. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202412492883248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412492883248.